Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/27/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. RKLB
9. SPCX
10. NKE

Go back to Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
(NASDAQ: ZNTL) Delayed: 4.04 +0.25 (6.60%)
Previous Close $3.79    52 Week High $ 
Open $3.75    52 Week Low $ 
Day High $4.07    P/E N/A 
Day Low $3.68    EPS $ 
Volume 7,490,438